Description: CJC‑1295 without DAC is a synthetic growth‑hormone‑releasing hormone (GHRH) analogue designed to stimulate pulsatile pituitary growth‑hormone (GH) release with a relatively short plasma half‑life compared with DAC‑conjugated forms. It increases GH secretion and downstream IGF‑1 signalling in preclinical studies and clinical research when used under controlled protocols.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory experimentation by qualified professionals only. Not for human or animal administration. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled.